Exp. Med. 183:1789–1796. 39. Ruedl, C., and M.F. Bachmann. 1999. CTL priming by CD81 and CD82 dendritic cells in vivo. Eur. J. Immunol. 29: 3762–3767. 40. Pulendran, B., J.L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C.R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune re- sponse in vivo. Proc. Natl. Acad. Sci. USA. 96:1036–1041. 41. Smith, A.L., and B.F. de St Groth. 1999. Antigen-pulsed CD8a1 dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J. Exp. Med. 189:593–598. 42. Maldonado-Lopez, R., T. De Smedt, P. Michel, J. Godfroid, B. Pajak, C. Heirman, K. Thielemans, O. Leo, J. Urbain, and M. Moser. 1999. CD8a1 and CD8a2 subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587–592. 43. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antago- nist peptides induce positive selection. Cell. 76:17–27. 44. Moore, M.W., F.R. Carbone, and M.J. Bevan. 1988. Intro- duction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 54:777–785. 45. Huang, A.Y., A.T. Bruce, D.M. Pardoll, and H.I. Levitsky. 1996. In vivo cross-priming of MHC class I-restricted anti- gens requires the TAP transporter. Immunity. 4:349–355. 46. Rock, K.L., and A.L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented pep- tides. Annu. Rev. Immunol. 17:739–779. 47. Castellino, F., P.E. Boucher, K. Eichelberg, M. Mayhew, J.E. Rothman, A.N. Houghton, and R.N. Germain. 2000. Re- ceptor-mediated uptake of antigen/heat shock protein com- plexes results in major histocompatibility complex class I anti- gen presentation via two distinct processing pathways. J. Exp. Med. 191:1957–1964. 48. Inaba, K., S. Turley, F. Yamaide, T. Iyoda, K. Mahnke, M. Inaba, M. Pack, M. Subklewe, B. Sauter, D. Sheff, et al. 1998. Efficient presentation of phagocytosed cellular frag- ments on the major histocompatibility complex class II prod- ucts of dendritic cells. J. Exp. Med. 188:2163–2173. 49. Steinman, R.M., S. Turley, I. Mellman, and K. Inaba. 2000. The induction of tolerance by dendritic cells that have cap- tured apoptotic cells. J. Exp. Med. 191:411–416. 50. De Smedt, T., B. Pajak, E. Muraille, L. Lespagnard, E. Hei- nen, P. De Baetselier, J. Urbain, O. Leo, and M. Moser. 1996. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184:1413–1424. 51. Reis e Sousa, C., and R.N. Germain. 1999. Analysis of adju- vant function by direct visualization of antigen presentation in vivo: endotoxin promotes accumulation of antigen-bear- ing dendritic cells in the T cell areas of lymphoid tissue. J. Im- munol. 162:6552–6561. 52. Reis e Sousa, C.R., S. Hieny, T. Scharton-Kersten, D. Jank- ovic, H. Charest, R.N. Germain, and A. Sher. 1997. In vivo microbial stimulation induces rapid CD40 ligand–indepen- dent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J. Exp. Med. 186:1819–1829. 53. Rovere, P., C. Vallinoto, A. Bondanza, M.C. Crosti, M. Re- scigno, P. Ricciardi-Castagnoli, C. Rugarli, and A.A. Man- fredi. 1998. Bystander apoptosis triggers dendritic cell matu- ration and antigen-presenting function. J. Immunol. 161: 4467–4471. 54. Sauter, B., M.L. Albert, L. Francisco, M. Larsson, S. Somer- san, and N. Bhardwaj. 2000. Consequences of cell death: ex- posure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimula- tory dendritic cells. J. Exp. Med. 191:423–434. 55. Crowley, M., K. Inaba, and R.M. Steinman. 1990. Dendritic cells are the principal cells in mouse spleen bearing immuno- genic fragments of foreign proteins. J. Exp. Med. 172:383– 386. 56. Huang, F.P., N. Platt, M. Wykes, J.R. Major, T.J. Powell, C.D. Jenkins, and G.G. MacPherson. 2000. A discrete sub- population of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:435–444. 57. Pulaski, B.A., K.Y. Yeh, N. Shastri, K.M. Maltby, D.P. Pen- ney, E.M. Lord, and J.G. Frelinger. 1996. Interleukin 3 en- hances cytotoxic T lymphocyte development and class I major histocompatibility complex “re-presentation” of exog- enous antigen by tumor-infiltrating antigen-presenting cells. Proc. Natl. Acad. Sci. USA. 93:3669–3674. 58. Green, E.A., F.S. Wong, K. Eshima, C. Mora, and R.A. Fla- vell. 2000. Neonatal tumor necrosis factor alpha promotes di- abetes in nonobese diabetic mice by CD154-independent antigen presentation to CD81 T cells. J. Exp. Med. 191:225– 238. 59. Chiodoni, C., P. Paglia, A. Stoppacciaro, M. Rodolfo, M. Parenza, and M.P. Colombo. 1999. Dendritic cells infiltrat- ing tumors cotransduced with granulocyte/macrophage col- ony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. J. Exp. Med. 190:125–133. 60. Fossum, S., and B. Rolstad. 1986. The roles of interdigitating cells and natural killer cells in the rapid rejection of allogeneic lymphocytes. Eur. J. Immunol. 16:440–450. 61. Carbone, F.R., and M.J. Bevan. 1990. Class I–restricted pro- cessing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171:377–387. 62. Toes, R.E., R.J. Blom, E. van der Voort, R. Offringa, C.J. Melief, and W.M. Kast. 1996. Protective antitumor immu- nity induced by immunization with completely allogeneic tumor cells. Cancer Res. 56:3782–3787. 63. de St Groth, B.F. 1998. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immu- nol. Today. 19:448–454. 64. Bennett, S.R., F.R. Carbone, F. Karamalis, R.A. Flavell, J.F. Miller, and W.R. Heath. 1998. Help for cytotoxic-T-cell re- sponses is mediated by CD40 signalling. Nature. 393:478– 480. 65. Ridge, J.P., F. Di Rosa, and P. Matzinger. 1998. A condi- tioned dendritic cell can be a temporal bridge between a CD41 T-helper and a T-killer cell. Nature. 393:474–478. 66. Schoenberger, S.P., R.E. Toes, E.I. van der Voort, R. Of- fringa, and C.J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Na- ture. 393:480–483. 67. Kurts, C., F.R. Carbone, M. Barnden, E. Blanas, J. Allison, W.R. Heath, and J.F. Miller. 1997. CD41 T cell help impairs CD81 T cell deletion induced by cross-presentation of self- antigens and favors autoimmunity. J. Exp. Med. 186:2057– 2062. 68. Diehl, L., A.T. den Boer, S.P. Schoenberger, E.I. van der Voort, T.N. Schumacher, C.J. Melief, R. Offringa, and R.E. Toes. 1999. CD40 activation in vivo overcomes peptide- 1694 CD81 Dendritic Cells Cross-prime CTLs In Vivo